King Edward Medical University
kemu.edu.pkTotal trials
71
Active
20
Phase 3
9
Total enrollment
7,438
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| G-CSF | — | — | — | — | — | 1 | |
| Antibiotics only | — | — | — | — | — | 1 | |
| Rosuvastatin 20 mg/day | — | — | — | — | — | 1 | |
| Atorvastatin 40 mg | — | — | — | — | — | 1 | |
| Buffered Local Anesthesia | — | — | — | — | — | 1 | |
| Vonoprazan 20 mg | — | — | — | — | — | 1 | |
| Tranexamic Acid | — | — | — | — | — | 1 | |
| Lactated Ringer 500ml | — | — | — | — | — | 1 | |
| Lactated Ringer 1000ml | — | — | — | — | — | 1 | |
| intralesional bleomycin | — | — | — | — | — | 1 | |
| 5-flourouracil and triamcinolone acetonide | — | — | — | — | — | 1 | |
| Calcium carbonate plus vitamin D3 | — | — | — | — | — | 1 | |
| Lignocaine Ointment | — | — | — | — | — | 1 | |
| Glyceryl Trinitrate Ointment 0.2% | — | — | — | — | — | 1 |
Next readouts
- 2025-12
- 2025-12-26
- 2026-01-01
- 2026-01-30
- 2026-02-20
- 2026-05-31
- 2026-06-30
- 2026-07-28
- 2026-12-31
Top conditions
- COVID-193
- Inguinal Hernia3
- Postoperative Pain2
- Burns2
- Cirrhoses, Liver1
- Thyroidectomy1
- Thyroid Gland Disease1
- Rheumatoid Arthritis1
Frequently asked questions about King Edward Medical University
- How many clinical trials does King Edward Medical University have on ClinicalTrials.gov?
- King Edward Medical University is listed as the lead sponsor on 71 clinical trials in ClinicalTrials.gov, 20 of which are currently active (recruiting, enrolling, or ongoing).
- How many of King Edward Medical University's trials are in Phase 3?
- 9 of King Edward Medical University's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does King Edward Medical University focus on?
- King Edward Medical University's most-studied conditions on ClinicalTrials.gov are COVID-19, Inguinal Hernia, Postoperative Pain, Burns, Cirrhoses, Liver.
- When are King Edward Medical University's next clinical trial readouts?
- King Edward Medical University has 9 upcoming primary-completion readouts tracked here; the soonest is “"Lignocaine vs GTN Ointment for Postoperative Pain After Hemorrhoidectomy")”, expected around 2025-12.